Kinetics and haematological effects of erythropoietin in horses.

The research explores the effects of erythropoietin (EPO) on horses, assessing how it affects the blood and how quickly it is processed by the body.

Kinetic Study of Erythropoietin

• The researchers carried out a plasma kinetic study on erythropoietin (EPO) involving four horses. This tested how the EPO drug moved and was processed within the horse’s body.
• The EPO was administered subcutaneously, that is, it was injected just under the skin of the horses.
• Horses given 30 IU/kg body weight of recombinant human erythropoietin (rhEPO), a biologically engineered form of EPO that is identical to the natural EPO produced in the human body.
• EPO plasma levels were measured at standardized intervals, done 48 hours before the injection and 60 hours after the injection.
• The assay used for measuring EPO levels was an immunoradiometric assay based on a sandwich technique which is a highly sensitive and specific method for detecting a specific protein in a sample.

Observations Post-administration

• The researchers observed the peak plasma concentration of EPO within 6 to 9 hours after its administration to the horses. There was a variance in the peak concentration ranging between 30 to 113 mIU/ml among the horses.
• The drug levels then began to decrease and returned to physiological value, or the normal levels found in the body, around 60 hours after the rhEPO injection.
• Reference values were also determined for plasma EPO concentrations in racehorses and sport equines, which ranged from 0 to 9 mlU/ml. Having reference values is important when interpreting the results of diagnostic tests and those derived from this study can serve as a benchmark for future studies.

Effects on Haematological Parameters

• After drug administration, the researchers did not observe any significant variations in red blood cell count, haemoglobin concentration, haematocrit, or mean red blood cell volume in the four horses used in the study, implying that there was no significant effect on the blood profile of the horses.
• Minimal variations were detected in these parameters in a horse given three successive doses of 120 IU rhEPO/kg body weight, suggesting that higher doses of rhEPO might be required to induce a visible effect on these blood parameters in horses.

The research, therefore, provides valuable insights about the kinetics and impacts of EPO on blood characteristics in horses which can be beneficial in equine care and medicine.